Immunological profiling of molecularly classified high-risk endometrial cancers identifies <i>POLE</i>-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition.

Oncoimmunology · 2017 · PMC5353925 · PMID 28344870

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

showed a trendp = 0.057so close (0.05 < p ≤ 0.1)

POLE -mutant ECs showed a trend toward increased expression of CD274 (PD-L1) ( p = 0.057).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Immunological profiling of molecularly classified high-risk endometrial cancers identifies &lt;i&gt;POLE&lt;/i&gt;-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition.

The sentences

Immunological profiling of molecularly classified high-risk endometrial cancers identifies <i>POLE</i>-mutant and microsatellite unstable carcinomas as candidates for checkpoint inhibition.